The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has received a total of $6.1 million in two grants to study deadly lung diseases that affect hundreds…
Dementia is a health issue that touches everyone, from the person afflicted to their friends and family to the individuals providing their care. As the aging population continues to grow,…
By conjuring the spell “Lumos!” wizards in the mythical world of Harry Potter could light up the tip of their magic wands and illuminate their surroundings. So, too, does LumosVar,…
The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, played a key role in a nationwide study that identified a method of starving pancreatic cancer cells, opening…
PathogenDx, Inc., the Arizona based technology company, which provides a DNA-based customized pathogen testing platform for the cannabis industry, announced today that over the past two months it has expanded key staff…
The HonorHealth vice president of research and a retired executive at W.L. Gore & Associates, Inc. have assumed new leadership roles with a statewide committee charged with advancing the biosciences…
Scottsdale-based Advanced Genomic Solutions (AGS) announced a partnership with Evexia Diagnostics. This partnership ensures that Evexia clients now have access to all AGS genetic testing services to further personalize patient treatment…
Cryptosporidiosis is the leading cause of waterborne diseases among humans in the United States, infecting almost 750,000 people each year, according to the Centers for Disease Control and Prevention. Globally in…
West Nile Virus — a potentially deadly infection spread by mosquito bites — is now a permanent resident of Arizona, according to a study by Northern Arizona University (NAU) and…
A sold-out crowd of doctors, scientists and healthcare professionals heard the latest numbers on the Scottsdale economy from Mayor W.J. “Jim” Lane. “Healthcare jobs in Scottsdale are growing at a…
The Arizona Bioindustry Association (AZBio) today announced that it has been awarded a $299,750 grant from the U.S. Economic Development Administration’s (EDA) 2018 Regional Innovation Strategies (RIS) program competition to support the…
Zion Medical, an Israeli biotech company developing HIV and cancer treatments, has announced the results of the first clinical trial of HIV-drug Gammora, eliminating up to 99% of the HIV…
